Fetuin-A associates with histones intracellularly and shuttles them to exosomes to promote focal adhesion assembly resulting in rapid adhesion and spreading in breast carcinoma cells

Experimental Cell Research

Volumn 328, Issue 2, 2014, Pages 388-400

  Nangami, Gladys ^a   Koumangoye, Rainelli ^b   Shawn Goodwin, J ^a   Sakwe, Amos M ^a   Marshall, Dana ^a   Higginbotham, James ^b   Ochieng, Josiah ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adhesion; Exosomes; Fetuin A; Histones; Tumor cells

Indexed keywords

FETUIN A; FIBRONECTIN; HEPARAN SULFATE; HEPARIN; HEPARIN LYASE; HEPARINASE III; HISTONE H2A; HISTONE H3; LAMININ; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; HEPARITINSULFATE LYASE; HISTONE; POLYSACCHARIDE LYASE; PROTEOGLYCAN;

ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL NUCLEUS; CELL SPREADING; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; EXOSOME; FOCAL ADHESION; HUMAN; HUMAN CELL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; BREAST TUMOR; CELL ADHESION; CELL LINE; CELL MEMBRANE; CYTOPLASM; FEMALE; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ALPHA-2-HS-GLYCOPROTEIN; BREAST NEOPLASMS; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; EXOSOMES; FEMALE; FIBRONECTINS; FOCAL ADHESIONS; HEK293 CELLS; HEPARIN; HEPARITIN SULFATE; HISTONES; HUMANS; LAMININ; POLYSACCHARIDE-LYASES; PROTEOGLYCANS;

EID: 84908192692     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.08.037     Document Type: Article

References (39)

1. Schafer C., Heiss A., Schwarz A., Westenfeld R., Ketteler M., Floege J., Muller-Esterl W., Schinke T., Jahnen-Dechent W. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Investig. 2003, 112:357-366.
2. Demetriou M., Binkert C., Sukhu B., Tenenbaum H.C., Dennis J.W. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J. Biol. Chem. 1996, 271:12755-12761.
3. Swallow C.J., Partridge E.A., Macmillan J.C., Tajirian T., DiGuglielmo G.M., Hay K., Szweras M., Jahnen-Dechent W., Wrana J.L., Redston M., Gallinger S., Dennis J.W. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression. Cancer Res. 2004, 64:6402-6409.
4. Guillory B., Sakwe A.M., Saria M., Thompson P., Adhiambo C., Koumangoye R., Ballard B., Binhazim A., Cone C., Jahanen-Dechent W., Ochieng J. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer. Am. J. Pathol. 2010, 177:2635-2644.
5. Goustin A.S., Derar N., Abou-Samra A.B. Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD beta-subunit of the insulin receptor. Cell Signal. 2013, 25:981-988.
6. Mori K., Emoto M., Inaba M. Fetuin-A: a multifunctional protein. Recent Pat. Endocr. Metab. Immune Drug Discov. 2011, 5:124-146.
7. Nie Z. Fetuin: its enigmatic property of growth promotion. Am. J. Physiol. 1992, 263:C551-562.
8. Brown W.M., Saunders N.R., Mollgard K., Dziegielewska K.M. Fetuin-an old friend revisited. Bioessays 1992, 14:749-755.
9. Sakwe A.M., Koumangoye R., Goodwin S.J., Ochieng J. Fetuin-A ({alpha}2HS-glycoprotein) is a major serum adhesive protein that mediates growth signaling in breast tumor cells. J. Biol. Chem. 2010, 285:41827-41835.
10. Kundranda M.N., Ray S., Saria M., Friedman D., Matrisian L.M., Lukyanov P., Ochieng J. Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A. Biochim. Biophys. Acta 2004, 1693:111-123.
11. Koumangoye R.B., Sakwe A.M., Goodwin J.S., Patel T., Ochieng J. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS One 2011, 6:e24234.
12. Watson K., Koumangoye R., Thompson P., Sakwe A.M., Patel T., Pratap S., Ochieng J. Fetuin-A triggers the secretion of a novel set of exosomes in detached tumor cells that mediate their adhesion and spreading. FEBS Lett. 2012, 586:3458-3463.
13. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., Curry W.T., Carter B.S., Krichevsky A.M., Breakefield X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470-1476.
14. Ochieng J., Pratap S., Khatua A.K., Sakwe A.M. Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes. Exp. Cell Res. 2009, 315:1875-1888.
15. Sceneay J., Smyth M.J., Moller A. The pre-metastatic niche: finding common ground. Cancer. Metastasis Rev. 2013, 32:449-464.
16. Clayton A., Turkes A., Dewitt S., Steadman R., Mason M.D., Hallett M.B. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J. 2004, 18:977-979.
17. Ngora H., Galli U.M., Miyazaki K., Zoller M. Membrane-bound and exosomal metastasis-associated C4.4A promotes migration by associating with the alpha(6)beta(4) integrin and MT1-MMP. Neoplasia 2012, 14:95-107.
18. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2:569-579.
19. Soekmadji C., Russell P.J., Nelson C.C. Exosomes in prostate cancer: putting together the pieces of a puzzle. Cancers 2013, 5:1522-1544.
20. Pemberton A.D., Brown J.K., Inglis N.F. Proteomic identification of interactions between histones and plasma proteins: implications for cytoprotection. Proteomics 2010, 10:1484-1493.
21. Xu J., Zhang X., Monestier M., Esmon N.L., Esmon C.T. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J. Immunol. 2011, 187:2626-2631.
22. Semeraro N., Ammollo C.T., Semeraro F., Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb. Res. 2012, 129:290-295.
23. Carestia A., Rivadeneyra L., Romaniuk M.A., Fondevila C., Negrotto S., Schattner M. Functional responses and molecular mechanisms involved in histone-mediated platelet activation. Thromb. Haemost. 2013, 110:1035-1045.
24. Babu M., Butland G., Pogoutse O., Li J., Greenblatt J.F., Emili A. Sequential peptide affinity purification system for the systematic isolation and identification of protein complexes from Escherichia coli. Methods Mol. Biol. 2009, 564:373-400.
25. Sakwe A.M., Nguyen T., Athanasopoulos V., Shire K., Frappier L. Identification and characterization of a novel component of the human minichromosome maintenance complex. Mol. Cell. Biol. 2007, 27:3044-3055.
26. Chen N.X., O'Neill K.D., Chen X., Duan D., Wang E., Sturek M.S., Edwards J.M., Moe S.M. Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins. Am. J. Physiol. Ren. Physiol. 2007, 292:F599-606.
27. Henriquez J.P., Casar J.C., Fuentealba L., Carey D.J., Brandan E. Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation. J. Cell Sci. 2002, 115:2041-2051.
28. Winograd-Katz S.E., Fassler R., Geiger B., Legate K.R. The integrin adhesome: from genes and proteins to human disease. Nat. Rev. Mol. Cell Biol. 2014, 15:273-288.
29. Jacquemet G., Humphries M.J., Caswell P.T. Role of adhesion receptor trafficking in 3D cell migration. Curr. Opin. Cell Biol. 2013, 25:627-632.
30. van Kilsdonk J.W., van Kempen L.C., van Muijen G.N., Ruiter D.J., Swart G.W. Soluble adhesion molecules in human cancers: sources and fates. Eur. J. Cell Biol. 2010, 89:415-427.
31. Kuo J.C. Mechanotransduction at focal adhesions: integrating cytoskeletal mechanics in migrating cells. J. Cell. Mol. Med. 2013, 17:704-712.
32. Kundranda M.N., Henderson M., Carter K.J., Gorden L., Binhazim A., Ray S., Baptiste T., Shokrani M., Leite-Browning M.L., Jahnen-Dechent W., Matrisian L.M., Ochieng J. The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms. Cancer Res. 2005, 65:499-506.
33. Li C.C., Eaton S.A., Young P.E., Lee M., Shuttleworth R., Humphreys D.T., Grau G.E., Combes V., Bebawy M., Gong J., Brammah S., Buckland M.E., Suter C.M. Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol. 2013, 10:1333-1344.
34. Schlie-Wolter S., Ngezahayo A., Chichkov B.N. The selective role of ECM components on cell adhesion, morphology, proliferation and communication in vitro. Exp. Cell Res. 2013, 319:1553-1561.
35. Bass M.D., Morgan M.R., Humphries M.J. Integrins and syndecan-4 make distinct, but critical, contributions to adhesion contact formation. Soft Matter 2007, 3:372-376.
36. Cardin A.D., Weintraub H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989, 9:21-32.
37. Christianson H.C., Svensson K.J., van Kuppevelt T.H., Li J.P., Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc. Natl. Acad. Sci. USA 2013, 110:17380-17385.
38. Higginbotham J.N., Demory Beckler M., Gephart J.D., Franklin J.L., Bogatcheva G., Kremers G.J., Piston D.W., Ayers G.D., McConnell R.E., Tyska M.J., Coffey R.J. Amphiregulin exosomes increase cancer cell invasion. Curr. Biol. 2011, 21:779-786.
39. Thompson C.A., Purushothaman A., Ramani V.C., Vlodavsky I., Sanderson R.D. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J. Biol. Chem. 2013, 288:10093-10099.